Tenvie Therapeutics: Funding, Investors & Team (Oct 2026)
Tenvie Therapeutics is a biotechnology company that aims to enhance the lives of patients with neurological, cardiometabolic, and ophthalmic diseases. They specialize in developing small molecules that target brain inflammation, metabolic issues, and problems with lysosomes. Tenvie's pipeline, which was originally developed by Denali Therapeutics, includes various therapeutics for treating these conditions. Their unique collection of small molecules is designed to penetrate the brain effectively and address key disease factors such as reducing inflammation, improving metabolism, and enhancing lysosomal function.
Tenvie Therapeutics has raised $200M across 1 funding round on record, the most recent a Series A of $200M announced in Jan 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tenvie Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Tenvie Therapeutics Funding Rounds
Tenvie Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Tenvie Therapeutics Funding Compared to Other Biotechnology Startups
Tenvie Therapeutics' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tenvie Therapeutics in Biotechnology and San Francisco
Companies Similar to Tenvie Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Tenvie Therapeutics Funding FAQs
What does Tenvie Therapeutics do?
Tenvie Therapeutics is a biotechnology company that aims to enhance the lives of patients with neurological, cardiometabolic, and ophthalmic diseases. They specialize in developing small molecules that target brain inflammation, metabolic issues, and problems with lysosomes. Tenvie's pipeline, which was originally developed by Denali Therapeutics, includes various therapeutics for treating these conditions. Their unique collection of small molecules is designed to penetrate the brain effectively and address key disease factors such as reducing inflammation, improving metabolism, and enhancing lysosomal function.
How much funding has Tenvie Therapeutics raised?
Tenvie Therapeutics has raised $200M across 1 round on record. The most recent is a Series A of $200M announced in Jan 2025.
When did Tenvie Therapeutics last raise funding?
Tenvie Therapeutics' most recent funding round on record is a Series A of $200M, announced in Jan 2025.
Who founded Tenvie Therapeutics?
FundedIQ lists Tony Estrada (Founder) at Tenvie Therapeutics.
Where is Tenvie Therapeutics headquartered?
Tenvie Therapeutics is based in San Francisco, California, United States.
How many employees does Tenvie Therapeutics have?
Tenvie Therapeutics is in the 11-50 employee band.
How does Tenvie Therapeutics' funding compare to other Biotechnology startups?
Tenvie Therapeutics' latest round of $200M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Tenvie Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tenvie Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.